LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Medical Gas Analyzers Market to Reach USD 325 Million by 2025

By LabMedica International staff writers
Posted on 01 Oct 2018
The global medical gas analyzers market was valued at USD 235 million in 2017 and is expected to grow at a CAGR of 4.1% from 2018 to 2025 to reach USD 325 million by 2025, driven by an upsurge in the adoption of medical gas analyzers, stringent regulations for medical gas systems, and increase in demand for advanced medical gas analyzing systems. An increase in the number of medical gas therapies due to a surge in the number of patients treated in intensive care units (ICUs), neonatal intensive care units (NICUs), and emergency departments, as well as a surge in number of hospitals & surgery centers will further support the market growth.

These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

Based on product, the multiple gas analyzers segment is expected to grow at a CAGR of 4.5% during the forecast period. On the basis of modality type, the portable analyzers segment held more than half the share of the medical gas analyzers market in 2017 and is expected to continue dominating the market throughout the forecast period. Based on end user, the ambulatory surgery centers segment is expected to register the fastest CAGR of 5.6% during the forecast period. Geographically, the medical gas analyzers market in Asia-Pacific is expected to register the highest CAGR of 5.4% during the forecast period.

Related Links:
Research and Markets


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
01 Oct 2018  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
01 Oct 2018  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
01 Oct 2018  |   Industry